Table of Content

1 Pediatric Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Vaccines
1.2 Pediatric Vaccines Segment by Type
1.2.1 Global Pediatric Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Pediatric Vaccines Segment by Application
1.3.1 Global Pediatric Vaccines Market Value by Application: (2024-2034)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Global Pediatric Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Vaccines Revenue 2018-2034
1.4.2 Global Pediatric Vaccines Sales 2018-2034
1.4.3 Global Pediatric Vaccines Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Pediatric Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pediatric Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pediatric Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Pediatric Vaccines Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Pediatric Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Vaccines, Product Type & Application
2.7 Pediatric Vaccines Market Competitive Situation and Trends
2.7.1 Pediatric Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pediatric Vaccines Players Market Share by Revenue
2.7.3 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pediatric Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Vaccines Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Pediatric Vaccines Global Pediatric Vaccines Sales by Region: 2018-2034
3.2.1 Global Pediatric Vaccines Sales by Region: 2018-2023
3.2.2 Global Pediatric Vaccines Sales by Region: 2024-2034
3.3 Global Pediatric Vaccines Global Pediatric Vaccines Revenue by Region: 2018-2034
3.3.1 Global Pediatric Vaccines Revenue by Region: 2018-2023
3.3.2 Global Pediatric Vaccines Revenue by Region: 2024-2034
3.4 North America Pediatric Vaccines Market Facts & Figures by Country
3.4.1 North America Pediatric Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Pediatric Vaccines Sales by Country (2018-2034)
3.4.3 North America Pediatric Vaccines Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pediatric Vaccines Market Facts & Figures by Country
3.5.1 Europe Pediatric Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Pediatric Vaccines Sales by Country (2018-2034)
3.5.3 Europe Pediatric Vaccines Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Pediatric Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Pediatric Vaccines Sales by Country (2018-2034)
3.6.3 Asia Pacific Pediatric Vaccines Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pediatric Vaccines Market Facts & Figures by Country
3.7.1 Latin America Pediatric Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Pediatric Vaccines Sales by Country (2018-2034)
3.7.3 Latin America Pediatric Vaccines Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Pediatric Vaccines Sales by Country (2018-2034)
3.8.3 Middle East and Africa Pediatric Vaccines Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Vaccines Sales by Type (2018-2034)
4.1.1 Global Pediatric Vaccines Sales by Type (2018-2023)
4.1.2 Global Pediatric Vaccines Sales by Type (2024-2034)
4.1.3 Global Pediatric Vaccines Sales Market Share by Type (2018-2034)
4.2 Global Pediatric Vaccines Revenue by Type (2018-2034)
4.2.1 Global Pediatric Vaccines Revenue by Type (2018-2023)
4.2.2 Global Pediatric Vaccines Revenue by Type (2024-2034)
4.2.3 Global Pediatric Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Pediatric Vaccines Price by Type (2018-2034)
5 Segment by Application
5.1 Global Pediatric Vaccines Sales by Application (2018-2034)
5.1.1 Global Pediatric Vaccines Sales by Application (2018-2023)
5.1.2 Global Pediatric Vaccines Sales by Application (2024-2034)
5.1.3 Global Pediatric Vaccines Sales Market Share by Application (2018-2034)
5.2 Global Pediatric Vaccines Revenue by Application (2018-2034)
5.2.1 Global Pediatric Vaccines Revenue by Application (2018-2023)
5.2.2 Global Pediatric Vaccines Revenue by Application (2024-2034)
5.2.3 Global Pediatric Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Pediatric Vaccines Price by Application (2018-2034)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Pediatric Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Pediatric Vaccines Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Pediatric Vaccines Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AstraZeneca Pediatric Vaccines Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Pediatric Vaccines Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Corporation Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Baxter Pediatric Vaccines Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 LG Life Sciences
6.10.1 LG Life Sciences Corporation Information
6.10.2 LG Life Sciences Description and Business Overview
6.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 LG Life Sciences Pediatric Vaccines Product Portfolio
6.10.5 LG Life Sciences Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Corporation Information
6.11.2 Lupin Pediatric Vaccines Description and Business Overview
6.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Lupin Pediatric Vaccines Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 S K Chemicals
6.12.1 S K Chemicals Corporation Information
6.12.2 S K Chemicals Pediatric Vaccines Description and Business Overview
6.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 S K Chemicals Pediatric Vaccines Product Portfolio
6.12.5 S K Chemicals Recent Developments/Updates
6.13 Mitsubishi Tanabe Pharma
6.13.1 Mitsubishi Tanabe Pharma Corporation Information
6.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Description and Business Overview
6.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
6.13.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.14 Janssen
6.14.1 Janssen Corporation Information
6.14.2 Janssen Pediatric Vaccines Description and Business Overview
6.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Janssen Pediatric Vaccines Product Portfolio
6.14.5 Janssen Recent Developments/Updates
6.15 Shenzhen Kangtai Biological Products
6.15.1 Shenzhen Kangtai Biological Products Corporation Information
6.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Description and Business Overview
6.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
6.15.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.16 Sinovac Biotech
6.16.1 Sinovac Biotech Corporation Information
6.16.2 Sinovac Biotech Pediatric Vaccines Description and Business Overview
6.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
6.16.5 Sinovac Biotech Recent Developments/Updates
6.17 Bharat Biotech
6.17.1 Bharat Biotech Corporation Information
6.17.2 Bharat Biotech Pediatric Vaccines Description and Business Overview
6.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Bharat Biotech Pediatric Vaccines Product Portfolio
6.17.5 Bharat Biotech Recent Developments/Updates
6.18 Crucell
6.18.1 Crucell Corporation Information
6.18.2 Crucell Pediatric Vaccines Description and Business Overview
6.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Crucell Pediatric Vaccines Product Portfolio
6.18.5 Crucell Recent Developments/Updates
6.19 Dynavax
6.19.1 Dynavax Corporation Information
6.19.2 Dynavax Pediatric Vaccines Description and Business Overview
6.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Dynavax Pediatric Vaccines Product Portfolio
6.19.5 Dynavax Recent Developments/Updates
6.20 Serum Institute of India
6.20.1 Serum Institute of India Corporation Information
6.20.2 Serum Institute of India Pediatric Vaccines Description and Business Overview
6.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Serum Institute of India Pediatric Vaccines Product Portfolio
6.20.5 Serum Institute of India Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Vaccines Industry Chain Analysis
7.2 Pediatric Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Vaccines Production Mode & Process
7.4 Pediatric Vaccines Sales and Marketing
7.4.1 Pediatric Vaccines Sales Channels
7.4.2 Pediatric Vaccines Distributors
7.5 Pediatric Vaccines Customers
8 Pediatric Vaccines Market Dynamics
8.1 Pediatric Vaccines Industry Trends
8.2 Pediatric Vaccines Market Drivers
8.3 Pediatric Vaccines Market Challenges
8.4 Pediatric Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pediatric Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Pediatric Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Pediatric Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pediatric Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Pediatric Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Pediatric Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Pediatric Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Pediatric Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Pediatric Vaccines, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Pediatric Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pediatric Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Pediatric Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Vaccines Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Pediatric Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Pediatric Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Pediatric Vaccines Sales by Region (2024-2034) & (K Units)
Table 20. Global Pediatric Vaccines Sales Market Share by Region (2024-2034)
Table 21. Global Pediatric Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Pediatric Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Pediatric Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Pediatric Vaccines Revenue Market Share by Region (2024-2034)
Table 25. North America Pediatric Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 28. North America Pediatric Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Pediatric Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Pediatric Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 33. Europe Pediatric Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Pediatric Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Pediatric Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Pediatric Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Pediatric Vaccines Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Pediatric Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Pediatric Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Pediatric Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Pediatric Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pediatric Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pediatric Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Pediatric Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Pediatric Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Pediatric Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Pediatric Vaccines Sales (K Units) by Type (2024-2034)
Table 52. Global Pediatric Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Pediatric Vaccines Sales Market Share by Type (2024-2034)
Table 54. Global Pediatric Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Pediatric Vaccines Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Pediatric Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Pediatric Vaccines Revenue Market Share by Type (2024-2034)
Table 58. Global Pediatric Vaccines Price (USD/Unit) by Type (2018-2023)
Table 59. Global Pediatric Vaccines Price (USD/Unit) by Type (2024-2034)
Table 60. Global Pediatric Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Pediatric Vaccines Sales (K Units) by Application (2024-2034)
Table 62. Global Pediatric Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Pediatric Vaccines Sales Market Share by Application (2024-2034)
Table 64. Global Pediatric Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Pediatric Vaccines Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Pediatric Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Pediatric Vaccines Revenue Market Share by Application (2024-2034)
Table 68. Global Pediatric Vaccines Price (USD/Unit) by Application (2018-2023)
Table 69. Global Pediatric Vaccines Price (USD/Unit) by Application (2024-2034)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. GlaxoSmithKline Pediatric Vaccines Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Merck Pediatric Vaccines Product
Table 79. Merck Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Pediatric Vaccines Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Sanofi Pediatric Vaccines Product
Table 89. Sanofi Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. AstraZeneca Pediatric Vaccines Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Pediatric Vaccines Product
Table 99. Novartis Recent Developments/Updates
Table 100. Takeda Pharmaceutical Corporation Information
Table 101. Takeda Pharmaceutical Description and Business Overview
Table 102. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Takeda Pharmaceutical Pediatric Vaccines Product
Table 104. Takeda Pharmaceutical Recent Developments/Updates
Table 105. Bavarian Nordic Corporation Information
Table 106. Bavarian Nordic Description and Business Overview
Table 107. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Bavarian Nordic Pediatric Vaccines Product
Table 109. Bavarian Nordic Recent Developments/Updates
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Baxter Pediatric Vaccines Product
Table 114. Baxter Recent Developments/Updates
Table 115. LG Life Sciences Corporation Information
Table 116. LG Life Sciences Description and Business Overview
Table 117. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. LG Life Sciences Pediatric Vaccines Product
Table 119. LG Life Sciences Recent Developments/Updates
Table 120. Lupin Corporation Information
Table 121. Lupin Description and Business Overview
Table 122. Lupin Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Lupin Pediatric Vaccines Product
Table 124. Lupin Recent Developments/Updates
Table 125. S K Chemicals Corporation Information
Table 126. S K Chemicals Description and Business Overview
Table 127. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. S K Chemicals Pediatric Vaccines Product
Table 129. S K Chemicals Recent Developments/Updates
Table 130. Mitsubishi Tanabe Pharma Corporation Information
Table 131. Mitsubishi Tanabe Pharma Description and Business Overview
Table 132. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Mitsubishi Tanabe Pharma Pediatric Vaccines Product
Table 134. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 135. Janssen Corporation Information
Table 136. Janssen Description and Business Overview
Table 137. Janssen Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Janssen Pediatric Vaccines Product
Table 139. Janssen Recent Developments/Updates
Table 140. Shenzhen Kangtai Biological Products Corporation Information
Table 141. Shenzhen Kangtai Biological Products Description and Business Overview
Table 142. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Shenzhen Kangtai Biological Products Pediatric Vaccines Product
Table 144. Shenzhen Kangtai Biological Products Recent Developments/Updates
Table 145. Sinovac Biotech Corporation Information
Table 146. Sinovac Biotech Description and Business Overview
Table 147. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Sinovac Biotech Pediatric Vaccines Product
Table 149. Sinovac Biotech Recent Developments/Updates
Table 150. Bharat Biotech Corporation Information
Table 151. Bharat Biotech Description and Business Overview
Table 152. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Bharat Biotech Pediatric Vaccines Product
Table 154. Bharat Biotech Recent Developments/Updates
Table 155. Crucell Corporation Information
Table 156. Crucell Description and Business Overview
Table 157. Crucell Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Crucell Pediatric Vaccines Product
Table 159. Crucell Recent Developments/Updates
Table 160. Dynavax Corporation Information
Table 161. Dynavax Description and Business Overview
Table 162. Dynavax Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Dynavax Pediatric Vaccines Product
Table 164. Dynavax Recent Developments/Updates
Table 165. Serum Institute of India Corporation Information
Table 166. Serum Institute of India Description and Business Overview
Table 167. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 168. Serum Institute of India Pediatric Vaccines Product
Table 169. Serum Institute of India Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Pediatric Vaccines Distributors List
Table 173. Pediatric Vaccines Customers List
Table 174. Pediatric Vaccines Market Trends
Table 175. Pediatric Vaccines Market Drivers
Table 176. Pediatric Vaccines Market Challenges
Table 177. Pediatric Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pediatric Vaccines
Figure 2. Global Pediatric Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Pediatric Vaccines Market Share by Type in 2024 & 2034
Figure 4. Diphtheria Product Picture
Figure 5. Influenza Product Picture
Figure 6. Hepatitis Product Picture
Figure 7. Pneumococcal Diseases Product Picture
Figure 8. Meningococcal Diseases Product Picture
Figure 9. Others Product Picture
Figure 10. Global Pediatric Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Pediatric Vaccines Market Share by Application in 2024 & 2034
Figure 12. Newborn
Figure 13. Infant
Figure 14. Child
Figure 15. Dolescent
Figure 16. Global Pediatric Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Pediatric Vaccines Market Size (2018-2034) & (US$ Million)
Figure 18. Global Pediatric Vaccines Sales (2018-2034) & (K Units)
Figure 19. Global Pediatric Vaccines Average Price (USD/Unit) & (2018-2034)
Figure 20. Pediatric Vaccines Report Years Considered
Figure 21. Pediatric Vaccines Sales Share by Manufacturers in 2024
Figure 22. Global Pediatric Vaccines Revenue Share by Manufacturers in 2024
Figure 23. The Global 5 and 10 Largest Pediatric Vaccines Players: Market Share by Revenue in 2024
Figure 24. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 25. Global Pediatric Vaccines Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 26. North America Pediatric Vaccines Sales Market Share by Country (2018-2034)
Figure 27. North America Pediatric Vaccines Revenue Market Share by Country (2018-2034)
Figure 28. U.S. Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Canada Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Europe Pediatric Vaccines Sales Market Share by Country (2018-2034)
Figure 31. Europe Pediatric Vaccines Revenue Market Share by Country (2018-2034)
Figure 32. Germany Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. France Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. U.K. Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Italy Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Russia Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Pediatric Vaccines Sales Market Share by Region (2018-2034)
Figure 38. Asia Pacific Pediatric Vaccines Revenue Market Share by Region (2018-2034)
Figure 39. China Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Japan Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. South Korea Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. India Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Australia Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. China Taiwan Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Indonesia Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Thailand Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Malaysia Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Latin America Pediatric Vaccines Sales Market Share by Country (2018-2034)
Figure 49. Latin America Pediatric Vaccines Revenue Market Share by Country (2018-2034)
Figure 50. Mexico Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Argentina Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Colombia Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Middle East & Africa Pediatric Vaccines Sales Market Share by Country (2018-2034)
Figure 55. Middle East & Africa Pediatric Vaccines Revenue Market Share by Country (2018-2034)
Figure 56. Turkey Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Saudi Arabia Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. UAE Pediatric Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. Global Sales Market Share of Pediatric Vaccines by Type (2018-2034)
Figure 60. Global Revenue Market Share of Pediatric Vaccines by Type (2018-2034)
Figure 61. Global Pediatric Vaccines Price (USD/Unit) by Type (2018-2034)
Figure 62. Global Sales Market Share of Pediatric Vaccines by Application (2018-2034)
Figure 63. Global Revenue Market Share of Pediatric Vaccines by Application (2018-2034)
Figure 64. Global Pediatric Vaccines Price (USD/Unit) by Application (2018-2034)
Figure 65. Pediatric Vaccines Value Chain
Figure 66. Pediatric Vaccines Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed